Wellness Bio Radar
Neuroscience-backed approaches to mental performance, stress resilience and cognitive optimisation.
232 articles
Rochester, Minnesota — Mayo Clinic researchers reported that an investigational vaccine successfully prompted the immune system to identify and attack specific KRAS mutations. These genetic changes…
Cold-water immersion offers no greater benefit for restoring muscle strength than heat-based therapy after intense exercise, according to recent scientific findings published in the Journal of…
Researchers at an Ohio medical center revealed a promising dual-targeted therapy that effectively combats metastatic triple-negative breast cancer in laboratory models, potentially offering a new…
Researchers at the University of Colorado Boulder and Massachusetts General Hospital have launched a nationwide clinical trial. The study tests a free, self-paced online mindfulness program called…
Researchers at the University of Pittsburgh have identified a specific group of unstable immune cells responsible for severe side effects in cancer patients. These adverse reactions affect up to…
Researchers have identified dabrafenib, an FDA-approved BRAF inhibitor, as a potential treatment for Cerebral Cavernous Malformation (CCM). This condition causes fragile vascular lesions in the brain…
Researchers recently reported that psilocybin therapy correlated with decreased markers of systemic inflammation. This finding emerged from a clinical trial focused on patients with Parkinson’s…
Millions of people across India struggle with sleeplessness, often staring at ceilings at two in the morning. Recent reviews suggest hypnotherapy provides a viable alternative for those who fail with…
Researchers have identified a critical link between childhood trauma and suicidal vulnerability among medical students. This study focuses on the specific psychological pathways that connect early…
Mental health practitioners are increasingly encountering clients who turn to AI chatbots for support. In response, a new six‑step framework has been released to help clinicians navigate the ethical…
A multicenter trial in the United States followed patients with newly diagnosed rheumatoid arthritis who received a strict treat‑to‑target regimen. Researchers tracked outcomes for a decade,…
VectorY Therapeutics has tripled the size of its Phase 1/2 PIONEER-ALS clinical trial, increasing enrollment from 12 to 36 participants to evaluate VTx-002, an investigational antibody targeting…